Park Min Jung, Kim Young Kon, Lee Mi Hee, Lee Jiyoung Hwang Won Jae
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12.
Gadoxetic acid and diffusion-weighted imaging (DWI) is increasingly used for the diagnosis of hepatocellular carcinoma (HCC). It is relevant to refine the diagnostic parameters for HCC, using state-of-the-art imaging techniques.
To validate usefulness of magnetic resonance imaging (MRI) criteria with gadoxetic acid-enhanced MRI and DWI for diagnosis of small HCC by differentiation from dysplastic nodule (DN) or regenerative nodule (RN) in cirrhotic patients with strongly suspected small HCC.
One hundred and eight patients with 102 HCCs and 29 benign nodules including 21 DNs and two large RNs (≤ 2.0 cm), and 40 patients with no HCC underwent gadoxetic acid-enhanced MRI and DWI. All patients also underwent MDCT. Index MR criteria for HCC were: (i) arterial hyperenhancement and hypointensity on hepatobiliary phase (HBP) with hyperintensity on DWI; (ii) hypovascular nodule with hyperintensity on DWI; (iii) arterial hyperenhancement and hypointensity on HBP without hyperintensity on DWI; (iv) arterial hyperenhancement and either iso- or hyperintensity on HBP, with hyperintensity on DWI; and (v) hyperintensity only on DWI. According to these criteria, MRI findings for HCCs and benign nodules were independently classified by two reviewers.
On multidetector-row computed tomography, 64 HCCs (62.7%) showed typical features for HCC while 13 (12.8%) were not identified. On MRI, 84 HCCs (82.4%) showed arterial hyperenhancement and hypointensity on HBP, and hyperintensity on DWI. Eight HCCs were regarded as hypovascular HCCs with hyperintensity DWI (category 2). One HCC (0.6 cm in diameter) was demonstrated only by DWI. For each observer, 101 (99.0%) and 100 HCCs (98.0%) were discernible when applying all MRI criteria for HCC, respectively. Three DNs also fit the HCC criteria, thus the specificity was 90.9% for both observers.
With the HCC criteria based on combined gadoxetic acid-enhanced MRI and DWI, it is possible to reliably diagnose small HCC including hypovascular HCCs.
钆塞酸二钠和扩散加权成像(DWI)越来越多地用于肝细胞癌(HCC)的诊断。采用先进的成像技术优化HCC的诊断参数具有重要意义。
通过鉴别肝硬化患者高度怀疑的小HCC与发育异常结节(DN)或再生结节(RN),验证钆塞酸增强磁共振成像(MRI)和DWI的MRI标准对小HCC诊断的有效性。
108例患者,其中102个HCC,29个良性结节,包括21个DN和2个大的RN(≤2.0 cm),40例无HCC的患者接受了钆塞酸增强MRI和DWI检查。所有患者均接受了多层螺旋CT(MDCT)检查。HCC的MRI指标为:(i)动脉期强化,肝胆期(HBP)低信号,DWI高信号;(ii)DWI高信号的乏血管结节;(iii)动脉期强化,HBP低信号,DWI无高信号;(iv)动脉期强化,HBP等信号或高信号,DWI高信号;(v)仅DWI高信号。根据这些标准,两位阅片者对HCC和良性结节的MRI表现进行独立分类。
在多排螺旋CT上,64个HCC(62.7%)表现出HCC的典型特征,而13个(12.8%)未被识别。在MRI上,84个HCC(82.4%)表现为动脉期强化,HBP低信号,DWI高信号。8个HCC被视为DWI高信号的乏血管HCC(2类)。1个HCC(直径0.6 cm)仅通过DWI显示。对于每位观察者,应用所有HCC的MRI标准时,分别有101个(99.0%)和100个HCC(98.0%)可被识别。3个DN也符合HCC标准,因此两位观察者的特异性均为90.9%。
基于钆塞酸增强MRI和DWI联合的HCC标准,能够可靠地诊断包括乏血管HCC在内的小HCC。